Altos Labs is a new biotechnology company focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine. A community of leading scientists, clinicians, and leaders from both academia and industry will work together towards this common mission. Altos will be initially based in the US in the San Francisco Bay Area and San Diego, and in the UK in Cambridge. The company will also have significant collaborations in Japan. The Altos Board of Directors and advisors include Nobel Laureates and scientific leaders.

Altos is dedicated to unraveling the deep biology of cellular rejuvenation programming. Our mission is to restore cell health and resilience to reverse disease, injury, and disabilities that occur throughout life.